Bristol-Myers Squibb claims to witness stronger-than-expected fourth quarter earnings, backed by sharply lower taxes and cost cuts, and augurs its 2010 earnings in line with Wall Street expectations, and Eli Lilly, on the other hand, has also seen a profit over the period.

According to a new study, heart attack patients who are given the blood thinner Plavix together with heartburn drug like Prilosec or Nexium nearly double their risk of another heart attack.

U. S. health regulators said they are investigating the effectiveness of the popular blood thinner Plavix which is the second-best-selling drug in the world, in some patients.